Pharmacy Council of India vs Proposed National Pharmacy Commission

Executive Summary & Quick Answer

The landscape of Indian pharmacy regulation stands at a historical crossroads. For over seven decades, the Pharmacy Council of India (PCI) has functioned as the central statutory body enforcing minimum educational standards and professional registration under the Pharmacy Act, 1948.

However, the Ministry of Health and Family Welfare (MoHFW) has introduced a major policy reform initiative: the Draft National Pharmacy Commission Bill, 2026. Modeled structurally after similar regulatory overhauls in healthcare—such as the replacement of the Medical Council of India (MCI) by the National Medical Commission (NMC)—the proposed legislation aims to repeal the Pharmacy Act of 1948 and establish an overarching National Pharmacy Commission (NPC) supported by four autonomous functional boards.

While headlines frequently proclaim that PCI has been replaced, the legal reality as of September 30, 2026, is straightforward: The proposed Commission is still in the draft legislative phase. PCI remains the active regulator.

Part 1: The Existing Framework — The Pharmacy Council of India (PCI)

The statutory governance of pharmacy in independent India originated with the enactment of the Pharmacy Act, 1948 (Act No. 8 of 1948). Enacted on March 4, 1948, the statute sought to regulate the profession and exercise of pharmacy, ensuring that only qualified individuals were permitted to compound, dispense, and supply medicinal products to the public.

Under Section 3 of the Act, the Central Government constituted the Pharmacy Council of India (PCI). Operating as a statutory body under the aegis of the Ministry of Health and Family Welfare, PCI relies on a tri-fold representation model comprising elected members, nominated members, and ex-officio healthcare officials.

Core Statutory Functions under the Pharmacy Act, 1948

• Education Regulations (ER): Under Section 10 of the Act, PCI frames the minimum standard of education required for qualification as a pharmacist. These standards dictate course duration, syllabus structure, practical training criteria, equipment requirements, and examination modalities for D.Pharm, B.Pharm, M.Pharm, and Pharm.D.
• Approval of Educational Institutions: Under Section 12, PCI inspects and accords formal approval to institutions offering pharmacy courses. An unapproved qualification does not entitle a graduate to register as a pharmacist.
• Central Register of Pharmacists: While individual state registrations are processed by respective State Pharmacy Councils (SPCs) under Section 19, PCI maintains the Central Register of Pharmacists under Section 15.1.

Part 2: The Proposed Architecture — The National Pharmacy Commission (NPC)

The Ministry of Health and Family Welfare initiated the structural overhaul of pharmacy regulation to address long-standing challenges within the higher education landscape, such as separating standard-setting from physical inspections, creating a dynamic national digital database, and encouraging research funding.

The Draft National Pharmacy Commission Bill, 2026 proposes an overarching 29-member Commission headquartered in New Delhi. Unlike PCI’s unified committee model, the proposed Commission delegates operational governance to Four Autonomous Boards:

Part 3: Comparative Analysis (PCI vs Proposed NPC)

The following detailed matrix presents a direct comparison between the current framework under the Pharmacy Act, 1948 and the proposed framework under the Draft National Pharmacy Commission Bill, 2026:

Part 4: Practical Stakeholder Breakdown

1. D.Pharm & B.Pharm Students

What Is Known: Academic programs remain fully governed by PCI Education Regulations. Examinations, internal assessments, and industrial training hours follow existing university and board patterns. The Diploma in Pharmacy Exit Examination (DPEE) regulations enacted by PCI apply as per current official notifications.

What May Change: Under the Draft NPC Bill, future graduates may take a unified National Exit Test (NExT) conducted by PERB to secure their professional license.

2. Pharm.D & M.Pharm Scholars

What Is Known: Pharm.D remains recognized as a regular doctoral-level professional degree under Pharmacy Practice Regulations. M.Pharm specializations remain fully valid for academic, clinical, research, and industrial roles.

What May Change: The proposed Pharmacy Research and Development Board (PRDB) seeks to create direct funding lines and industry research links for post-graduate scholars.

3. Registered Pharmacists

What Is Known: Registrations issued by State Pharmacy Councils under Section 32 and 33 of the Pharmacy Act, 1948 remain completely valid. Renewal schedules must be maintained according to respective state rules.

What May Change: Active state registrations will migrate into the centralized National Pharmacy Register. Pharmacists will receive a unified national registration number and undergo digital renewals linked to Continuing Professional Education (CPE) credits.

4. Pharmacy Faculty Members & Colleges

What Is Known: Faculty eligibility, cadre structures, student-to-teacher ratios, and qualification norms are defined under PCI Regulations. Institutions must obtain annual PCI approval and adhere to intake limits.

What May Change: Colleges will transition from binary PCI approvals to an outcome-based scoring and rating system administered by PARB, published on a public portal.

Part 5: Career and Employment Implications

A common misconception among pharmacy professionals is that changing a central regulatory statute automatically alters state-level recruitment rules for public sector employment.

Government Pharmacist & Hospital Positions: Central and state government recruitment rules for pharmacists in organizations such as Railway Recruitment Boards (RRB), ESIC, AIIMS, and State Health Departments are framed under independent service rules governed by Article 309 of the Constitution of India. Transitioning from PCI to NPC will not alter basic eligibility so long as the candidate holds a recognized degree or diploma and active registration.

Drug Inspector (DI) Recruitment: Qualifications for Drug Inspectors are governed strictly by Rule 49 of the Drugs and Cosmetics Rules, 1945. The proposed NPC Bill does not amend the Drugs and Cosmetics Act, 1940. Eligibility remains bound by the statutory qualifications prescribed under Rule 49.

Part 6: Myth vs Fact

MYTH: PCI has been abolished in 2026.
FACT: False. PCI is fully operational under the statutory authority of the Pharmacy Act, 1948. It continues to conduct inspections, grant institutional approvals, and maintain the Central Register.

MYTH: The National Pharmacy Commission is already active and taking over college approvals.
FACT: False. The National Pharmacy Commission Bill, 2026 is currently a draft legislative proposal. It has not been passed by Parliament or notified in the Gazette of India.

MYTH: Existing D.Pharm, B.Pharm, and Pharm.D degrees will lose recognition under the new system.
FACT: False. Sections 58 and 59 of the Draft NPC Bill contain explicit statutory savings clauses that legally protect all qualifications, enrollments, and degrees recognized under the Pharmacy Act, 1948.

MYTH: Registered pharmacists will have to sit for a re-examination to retain their license.
FACT: False. Already registered pharmacists will be automatically transitioned to the National Pharmacy Register without re-examination.

Part 7: Frequently Asked Questions (FAQs)